Uncategorized

Zepbound copycats remain online despite FDA ban – CNBC

Posted on Author Tim Hodges Comments Off on Zepbound copycats remain online despite FDA ban – CNBC
  1. Zepbound copycats remain online despite FDA ban  CNBC
  2. Sale of Ozempic Knockoffs Is Supposed to End Soon. Telehealth Companies Aren’t Happy.  The Wall Street Journal
  3. Patients scramble as cheaper obesity drug alternatives disappear  NPR
  4. Ozempic: Sale of Compounded Versions of Some Weight Loss Drugs to End  Healthline
  5. Restrictions on cheaper weight-loss drug alternatives Wegovy, Zepbound  Newsday